(MedPage Today) — An investigational antihypertensive drug resolved or reduced hypertension in patients with primary aldosteronism, according to a small phase IIa trial.
By week 12, systolic blood pressure was reduced by a mean of 24.9 mm Hg…
Source link : https://www.medpagetoday.com/endocrinology/generalendocrinology/116703
Author :
Publish date : 2025-07-28 20:11:00
Copyright for syndicated content belongs to the linked Source.
